We are live on ! Find out more
FDMT icon

4D Molecular Therapeutics
FDMT

77 hedge funds and large institutions have $541M invested in 4D Molecular Therapeutics in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

514% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 7

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

22% more funds holding

Funds holding: 63 → 77 (+14)

5.87% more ownership

Funds ownership: 71% → 76.86% (+5.9%)

5% more capital invested

Capital invested by funds: $515M → $541M (+$26.4M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

98% less call options, than puts

Call options by funds: $9K | Put options by funds: $495K

Holders
77
Holders Change
+14
Holders Change %
+22.22%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
43
Reduced
7
Closed
8
Calls
$9K
Puts
$495K
Net Calls
-$486K
Net Calls Change
-$484K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$23M
2
PWM
Perigon Wealth Management
California
+$18.8M
3
OCA
Octagon Capital Advisors
New York
+$17.6M
4
BlackRock
BlackRock
New York
+$15.9M
5
ACM
Aquilo Capital Management
California
+$10M

Top Sellers

Rank Fund Capital Flow
1
Alkeon Capital Management
Alkeon Capital Management
New York
-$16.2M
2
CC
Casdin Capital
New York
-$13.7M
3
PA
Perceptive Advisors
New York
-$10.1M
4
CC
Centiva Capital
New York
-$7.22M
5
Millennium Management
Millennium Management
New York
-$4.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$1.92M +$1.83M +74,824 +593%
Citigroup
27
Citigroup
New York
$1.82M +$1.97M +80,369 +2,867%
Rafferty Asset Management
28
Rafferty Asset Management
New York
$1.66M +$1.86M +75,713 New
Two Sigma Investments
29
Two Sigma Investments
New York
$1.55M +$1.74M +70,847 New
UBS Group
30
UBS Group
Switzerland
$1.52M +$1.67M +68,094 +5,421%
Russell Investments Group
31
Russell Investments Group
United Kingdom
$1.25M -$1.12M -45,778 -45%
Swiss National Bank
32
Swiss National Bank
Switzerland
$1.17M +$581K +23,700 +80%
Renaissance Technologies
33
Renaissance Technologies
New York
$983K +$1.1M +44,800 New
PPA
34
Parametric Portfolio Associates
Washington
$811K -$137K -5,582 -13%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$781K +$327K +13,349 +60%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$743K +$830K +33,856 New
Goldman Sachs
37
Goldman Sachs
New York
$735K +$584K +23,809 +246%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$704K +$473K +19,300 +151%
Citadel Advisors
39
Citadel Advisors
Florida
$700K +$442K +18,041 +130%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$674K +$151K +6,177 +25%
JF
41
Jump Financial
Illinois
$583K +$652K +26,593 New
Wells Fargo
42
Wells Fargo
California
$444K +$308K +12,550 +163%
CSS
43
Cubist Systematic Strategies
Connecticut
$393K +$439K +17,913 New
Deutsche Bank
44
Deutsche Bank
Germany
$379K +$10.3K +422 +3%
CS
45
Credit Suisse
Switzerland
$329K +$148K +6,023 +67%
AIG
46
American International Group
New York
$326K +$82.7K +3,374 +29%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$315K +$120K +4,879 +51%
UBS AM
48
UBS AM
Illinois
$289K +$323K +13,182 New
Mitsubishi UFJ Asset Management
49
Mitsubishi UFJ Asset Management
Japan
$284K +$307K +12,538 New
M&T Bank
50
M&T Bank
New York
$270K +$16.5K +672 +6%
1
2
3 4

FDMT Hedge Fund Activity: Q4 2021 in Review

77 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in 4D Molecular Therapeutics (FDMT) for Q4 2021, worth a combined $541M — up 5.1% from $515M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FDMT positions and 8 closed out — a net gain of 14 holders — while 43 added to existing stakes and 7 trimmed.

The largest buyer was State Street, adding an estimated $23M. The largest seller was Alkeon Capital Management, exiting entirely with an estimated $16.2M sold.

  • 77 institutional investors held 4D Molecular Therapeutics (FDMT) as of Q4 2021, up from 63 in Q3 2021.
  • Funds reported $541M of 4D Molecular Therapeutics stock for Q4 2021, up 5.1% quarter-over-quarter.
  • 22 funds opened new 4D Molecular Therapeutics positions in Q4 2021 and 8 closed out, a net change of +14 holders.
  • The largest 4D Molecular Therapeutics buyer in Q4 2021 was State Street, an estimated $23M added.
  • The largest 4D Molecular Therapeutics seller in Q4 2021 was Alkeon Capital Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2021.